nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Gefitinib—lung cancer	0.0886	0.339	CbGbCtD
Glimepiride—CYP2C9—Teniposide—lung cancer	0.0859	0.329	CbGbCtD
Glimepiride—CYP2C9—Paclitaxel—lung cancer	0.0479	0.184	CbGbCtD
Glimepiride—CYP2C9—Cisplatin—lung cancer	0.0385	0.148	CbGbCtD
Glimepiride—Gliclazide—VEGFA—lung cancer	0.0046	0.366	CrCbGaD
Glimepiride—Glyburide—ABCC3—lung cancer	0.00306	0.244	CrCbGaD
Glimepiride—Glyburide—ABCG2—lung cancer	0.00149	0.118	CrCbGaD
Glimepiride—Gliclazide—ALB—lung cancer	0.00124	0.0983	CrCbGaD
Glimepiride—Chlorpropamide—ABCB1—lung cancer	0.000917	0.073	CrCbGaD
Glimepiride—Glyburide—ALB—lung cancer	0.000649	0.0516	CrCbGaD
Glimepiride—Glyburide—ABCB1—lung cancer	0.00062	0.0493	CrCbGaD
Glimepiride—Fatigue—Irinotecan—lung cancer	0.00054	0.000883	CcSEcCtD
Glimepiride—Pruritus—Vinorelbine—lung cancer	0.000537	0.000878	CcSEcCtD
Glimepiride—Hypotension—Cisplatin—lung cancer	0.000531	0.000869	CcSEcCtD
Glimepiride—Anxiety—Paclitaxel—lung cancer	0.000531	0.000868	CcSEcCtD
Glimepiride—Erythema—Docetaxel—lung cancer	0.00053	0.000867	CcSEcCtD
Glimepiride—Malnutrition—Docetaxel—lung cancer	0.00053	0.000867	CcSEcCtD
Glimepiride—Decreased appetite—Gemcitabine—lung cancer	0.00053	0.000867	CcSEcCtD
Glimepiride—Nausea—Topotecan—lung cancer	0.000527	0.000862	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000527	0.000861	CcSEcCtD
Glimepiride—Fatigue—Gemcitabine—lung cancer	0.000526	0.00086	CcSEcCtD
Glimepiride—Confusional state—Etoposide—lung cancer	0.000525	0.000859	CcSEcCtD
Glimepiride—Nausea—Erlotinib—lung cancer	0.000522	0.000853	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—lung cancer	0.000521	0.000852	CcSEcCtD
Glimepiride—Dry mouth—Paclitaxel—lung cancer	0.000521	0.000852	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—lung cancer	0.000521	0.000852	CcSEcCtD
Glimepiride—Diarrhoea—Vinorelbine—lung cancer	0.00052	0.00085	CcSEcCtD
Glimepiride—Feeling abnormal—Irinotecan—lung cancer	0.000516	0.000844	CcSEcCtD
Glimepiride—Confusional state—Paclitaxel—lung cancer	0.000515	0.000842	CcSEcCtD
Glimepiride—Gastrointestinal pain—Irinotecan—lung cancer	0.000512	0.000837	CcSEcCtD
Glimepiride—Anaphylactic shock—Paclitaxel—lung cancer	0.000511	0.000835	CcSEcCtD
Glimepiride—Paraesthesia—Cisplatin—lung cancer	0.000511	0.000835	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—lung cancer	0.00051	0.000834	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—lung cancer	0.000508	0.000831	CcSEcCtD
Glimepiride—Dyspnoea—Cisplatin—lung cancer	0.000507	0.000829	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—lung cancer	0.000504	0.000823	CcSEcCtD
Glimepiride—Feeling abnormal—Gemcitabine—lung cancer	0.000503	0.000822	CcSEcCtD
Glimepiride—Shock—Paclitaxel—lung cancer	0.000502	0.000822	CcSEcCtD
Glimepiride—Dizziness—Vinorelbine—lung cancer	0.000502	0.000821	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—lung cancer	0.000501	0.000819	CcSEcCtD
Glimepiride—Thrombocytopenia—Paclitaxel—lung cancer	0.0005	0.000818	CcSEcCtD
Glimepiride—Tachycardia—Paclitaxel—lung cancer	0.000498	0.000815	CcSEcCtD
Glimepiride—Anorexia—Etoposide—lung cancer	0.000497	0.000812	CcSEcCtD
Glimepiride—Abdominal pain—Irinotecan—lung cancer	0.000495	0.00081	CcSEcCtD
Glimepiride—Decreased appetite—Cisplatin—lung cancer	0.000494	0.000808	CcSEcCtD
Glimepiride—Hyperhidrosis—Paclitaxel—lung cancer	0.000494	0.000807	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Cisplatin—lung cancer	0.000491	0.000803	CcSEcCtD
Glimepiride—Anaemia—Docetaxel—lung cancer	0.00049	0.000802	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—lung cancer	0.000489	0.0008	CcSEcCtD
Glimepiride—Anorexia—Paclitaxel—lung cancer	0.000487	0.000796	CcSEcCtD
Glimepiride—Hypotension—Etoposide—lung cancer	0.000487	0.000796	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000485	0.000793	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000485	0.000793	CcSEcCtD
Glimepiride—Vomiting—Vinorelbine—lung cancer	0.000483	0.000789	CcSEcCtD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000482	0.00419	CbGpPWpGaD
Glimepiride—Rash—Vinorelbine—lung cancer	0.000479	0.000783	CcSEcCtD
Glimepiride—Dermatitis—Vinorelbine—lung cancer	0.000478	0.000782	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—lung cancer	0.000478	0.000782	CcSEcCtD
Glimepiride—Hypotension—Paclitaxel—lung cancer	0.000477	0.00078	CcSEcCtD
Glimepiride—Headache—Vinorelbine—lung cancer	0.000476	0.000778	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—lung cancer	0.000475	0.000777	CcSEcCtD
Glimepiride—Leukopenia—Docetaxel—lung cancer	0.000475	0.000776	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—lung cancer	0.00047	0.000769	CcSEcCtD
Glimepiride—Sweating—Methotrexate—lung cancer	0.000469	0.000767	CcSEcCtD
Glimepiride—Palpitations—Docetaxel—lung cancer	0.000469	0.000766	CcSEcCtD
Glimepiride—Feeling abnormal—Cisplatin—lung cancer	0.000469	0.000766	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—lung cancer	0.000468	0.000765	CcSEcCtD
Glimepiride—Loss of consciousness—Docetaxel—lung cancer	0.000466	0.000762	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—lung cancer	0.000464	0.000759	CcSEcCtD
Glimepiride—Somnolence—Etoposide—lung cancer	0.000463	0.000757	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—lung cancer	0.000463	0.000757	CcSEcCtD
Glimepiride—Insomnia—Paclitaxel—lung cancer	0.000462	0.000755	CcSEcCtD
Glimepiride—Hypersensitivity—Irinotecan—lung cancer	0.000461	0.000754	CcSEcCtD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000461	0.00401	CbGpPWpGaD
Glimepiride—Convulsion—Docetaxel—lung cancer	0.00046	0.000751	CcSEcCtD
Glimepiride—Paraesthesia—Paclitaxel—lung cancer	0.000459	0.00075	CcSEcCtD
Glimepiride—Hypertension—Docetaxel—lung cancer	0.000458	0.000749	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—lung cancer	0.000457	0.000747	CcSEcCtD
Glimepiride—Dyspnoea—Paclitaxel—lung cancer	0.000455	0.000745	CcSEcCtD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000455	0.00396	CbGpPWpGaD
Glimepiride—Somnolence—Paclitaxel—lung cancer	0.000454	0.000742	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—lung cancer	0.000453	0.00074	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—lung cancer	0.000451	0.000738	CcSEcCtD
Glimepiride—Nausea—Vinorelbine—lung cancer	0.000451	0.000738	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—lung cancer	0.00045	0.000735	CcSEcCtD
Glimepiride—Dyspepsia—Paclitaxel—lung cancer	0.00045	0.000735	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—BRAF—lung cancer	0.000449	0.00391	CbGpPWpGaD
Glimepiride—Asthenia—Irinotecan—lung cancer	0.000449	0.000735	CcSEcCtD
Glimepiride—Fatigue—Etoposide—lung cancer	0.000449	0.000734	CcSEcCtD
Glimepiride—Decreased appetite—Paclitaxel—lung cancer	0.000444	0.000726	CcSEcCtD
Glimepiride—Dry mouth—Docetaxel—lung cancer	0.000442	0.000722	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000441	0.000721	CcSEcCtD
Glimepiride—Fatigue—Paclitaxel—lung cancer	0.00044	0.00072	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—lung cancer	0.000439	0.000718	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—lung cancer	0.000439	0.000718	CcSEcCtD
Glimepiride—Asthenia—Gemcitabine—lung cancer	0.000438	0.000716	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—lung cancer	0.000436	0.000714	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—lung cancer	0.000434	0.000709	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—lung cancer	0.000433	0.000708	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—lung cancer	0.000432	0.000707	CcSEcCtD
Glimepiride—Pruritus—Gemcitabine—lung cancer	0.000432	0.000706	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—lung cancer	0.000429	0.000702	CcSEcCtD
Glimepiride—Diarrhoea—Irinotecan—lung cancer	0.000428	0.000701	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—lung cancer	0.000426	0.000697	CcSEcCtD
Glimepiride—Shock—Docetaxel—lung cancer	0.000426	0.000696	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—lung cancer	0.000424	0.000693	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—lung cancer	0.000424	0.000693	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—lung cancer	0.000423	0.000692	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—lung cancer	0.000423	0.000691	CcSEcCtD
Glimepiride—Feeling abnormal—Paclitaxel—lung cancer	0.000421	0.000688	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00042	0.000687	CcSEcCtD
Glimepiride—Hypersensitivity—Cisplatin—lung cancer	0.000419	0.000685	CcSEcCtD
Glimepiride—Gastrointestinal pain—Paclitaxel—lung cancer	0.000418	0.000683	CcSEcCtD
Glimepiride—Diarrhoea—Gemcitabine—lung cancer	0.000417	0.000682	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—lung cancer	0.000415	0.000679	CcSEcCtD
Glimepiride—Dizziness—Irinotecan—lung cancer	0.000414	0.000677	CcSEcCtD
Glimepiride—Urticaria—Etoposide—lung cancer	0.000414	0.000677	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—lung cancer	0.000413	0.000675	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—lung cancer	0.000413	0.000675	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—lung cancer	0.000412	0.000673	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000408	0.00355	CbGpPWpGaD
Glimepiride—Asthenia—Cisplatin—lung cancer	0.000408	0.000667	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—lung cancer	0.000406	0.000664	CcSEcCtD
Glimepiride—Urticaria—Paclitaxel—lung cancer	0.000406	0.000663	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—lung cancer	0.000405	0.000661	CcSEcCtD
Glimepiride—ABCC8—Metabolism—COL4A3BP—lung cancer	0.000404	0.00352	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AZIN2—lung cancer	0.000404	0.00352	CbGpPWpGaD
Glimepiride—Abdominal pain—Paclitaxel—lung cancer	0.000404	0.00066	CcSEcCtD
Glimepiride—Vomiting—Irinotecan—lung cancer	0.000398	0.000651	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000396	0.00345	CbGpPWpGaD
Glimepiride—Agranulocytosis—Doxorubicin—lung cancer	0.000395	0.000646	CcSEcCtD
Glimepiride—Rash—Irinotecan—lung cancer	0.000395	0.000646	CcSEcCtD
Glimepiride—Dermatitis—Irinotecan—lung cancer	0.000394	0.000645	CcSEcCtD
Glimepiride—Headache—Irinotecan—lung cancer	0.000392	0.000642	CcSEcCtD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000392	0.00341	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—COL4A3BP—lung cancer	0.000392	0.00341	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AZIN2—lung cancer	0.000392	0.00341	CbGpPWpGaD
Glimepiride—Insomnia—Docetaxel—lung cancer	0.000392	0.00064	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—lung cancer	0.000389	0.000636	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—lung cancer	0.000389	0.000636	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—lung cancer	0.000388	0.000634	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—lung cancer	0.000387	0.000633	CcSEcCtD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000387	0.00336	CbGpPWpGaD
Glimepiride—Dyspnoea—Docetaxel—lung cancer	0.000386	0.000631	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—lung cancer	0.000385	0.000629	CcSEcCtD
Glimepiride—Rash—Gemcitabine—lung cancer	0.000385	0.000629	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—lung cancer	0.000384	0.000628	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—lung cancer	0.000384	0.000628	CcSEcCtD
Glimepiride—Erythema—Methotrexate—lung cancer	0.000382	0.000625	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—lung cancer	0.000382	0.000625	CcSEcCtD
Glimepiride—Headache—Gemcitabine—lung cancer	0.000382	0.000625	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—lung cancer	0.000381	0.000623	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—lung cancer	0.00038	0.000622	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GSTM2—lung cancer	0.000378	0.00329	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CNDP2—lung cancer	0.000378	0.00329	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—MDM2—lung cancer	0.000376	0.00328	CbGpPWpGaD
Glimepiride—Decreased appetite—Docetaxel—lung cancer	0.000376	0.000615	CcSEcCtD
Glimepiride—Hypersensitivity—Paclitaxel—lung cancer	0.000376	0.000615	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—RAF1—lung cancer	0.000375	0.00326	CbGpPWpGaD
Glimepiride—Gastrointestinal disorder—Docetaxel—lung cancer	0.000374	0.000611	CcSEcCtD
Glimepiride—Asthenia—Etoposide—lung cancer	0.000374	0.000611	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000373	0.00325	CbGpPWpGaD
Glimepiride—Fatigue—Docetaxel—lung cancer	0.000373	0.00061	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM2—lung cancer	0.000372	0.00324	CbGpPWpGaD
Glimepiride—Nausea—Irinotecan—lung cancer	0.000372	0.000608	CcSEcCtD
Glimepiride—Pruritus—Etoposide—lung cancer	0.000369	0.000603	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—lung cancer	0.000366	0.000599	CcSEcCtD
Glimepiride—Asthenia—Paclitaxel—lung cancer	0.000366	0.000599	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—lung cancer	0.000362	0.000593	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—lung cancer	0.000362	0.000591	CcSEcCtD
Glimepiride—Pruritus—Paclitaxel—lung cancer	0.000361	0.000591	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—lung cancer	0.00036	0.000589	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—lung cancer	0.00036	0.000588	CcSEcCtD
Glimepiride—Rash—Cisplatin—lung cancer	0.000359	0.000586	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—lung cancer	0.000358	0.000586	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000358	0.00312	CbGpPWpGaD
Glimepiride—Feeling abnormal—Docetaxel—lung cancer	0.000357	0.000583	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—lung cancer	0.000356	0.000583	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—lung cancer	0.000354	0.000579	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—lung cancer	0.000353	0.000578	CcSEcCtD
Glimepiride—Diarrhoea—Paclitaxel—lung cancer	0.000349	0.000571	CcSEcCtD
Glimepiride—Dizziness—Etoposide—lung cancer	0.000344	0.000563	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ATP5H—lung cancer	0.000343	0.00299	CbGpPWpGaD
Glimepiride—Abdominal pain—Docetaxel—lung cancer	0.000342	0.00056	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—lung cancer	0.000342	0.00056	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP2A7—lung cancer	0.000342	0.00297	CbGpPWpGaD
Glimepiride—Arrhythmia—Doxorubicin—lung cancer	0.00034	0.000556	CcSEcCtD
Glimepiride—Dizziness—Paclitaxel—lung cancer	0.000338	0.000552	CcSEcCtD
Glimepiride—Nausea—Cisplatin—lung cancer	0.000338	0.000552	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2A7—lung cancer	0.000337	0.00293	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ATP5H—lung cancer	0.000333	0.0029	CbGpPWpGaD
Glimepiride—Convulsion—Methotrexate—lung cancer	0.000331	0.000542	CcSEcCtD
Glimepiride—Vomiting—Etoposide—lung cancer	0.000331	0.000542	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—lung cancer	0.000331	0.000541	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—lung cancer	0.000331	0.000541	CcSEcCtD
Glimepiride—Rash—Etoposide—lung cancer	0.000328	0.000537	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—lung cancer	0.000328	0.000537	CcSEcCtD
Glimepiride—Headache—Etoposide—lung cancer	0.000326	0.000534	CcSEcCtD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000326	0.00283	CbGpPWpGaD
Glimepiride—Tension—Doxorubicin—lung cancer	0.000325	0.000531	CcSEcCtD
Glimepiride—Vomiting—Paclitaxel—lung cancer	0.000325	0.000531	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000325	0.00283	CbGpPWpGaD
Glimepiride—Rash—Paclitaxel—lung cancer	0.000322	0.000527	CcSEcCtD
Glimepiride—Dermatitis—Paclitaxel—lung cancer	0.000322	0.000526	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—lung cancer	0.000322	0.000526	CcSEcCtD
Glimepiride—Headache—Paclitaxel—lung cancer	0.00032	0.000523	CcSEcCtD
Glimepiride—Hypersensitivity—Docetaxel—lung cancer	0.000319	0.000522	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000318	0.00276	CbGpPWpGaD
Glimepiride—Confusional state—Methotrexate—lung cancer	0.000315	0.000514	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—lung cancer	0.000312	0.00051	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—lung cancer	0.000312	0.00051	CcSEcCtD
Glimepiride—Asthenia—Docetaxel—lung cancer	0.000311	0.000508	CcSEcCtD
Glimepiride—Nausea—Etoposide—lung cancer	0.000309	0.000506	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—lung cancer	0.000306	0.000501	CcSEcCtD
Glimepiride—ABCC8—Metabolism—PLBD1—lung cancer	0.000306	0.00266	CbGpPWpGaD
Glimepiride—Anaemia—Doxorubicin—lung cancer	0.000306	0.0005	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—lung cancer	0.000305	0.0005	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GSTA3—lung cancer	0.000304	0.00265	CbGpPWpGaD
Glimepiride—Agitation—Doxorubicin—lung cancer	0.000304	0.000497	CcSEcCtD
Glimepiride—Nausea—Paclitaxel—lung cancer	0.000303	0.000496	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—lung cancer	0.000302	0.000493	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTA3—lung cancer	0.0003	0.00261	CbGpPWpGaD
Glimepiride—Anorexia—Methotrexate—lung cancer	0.000297	0.000486	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—PLBD1—lung cancer	0.000297	0.00258	CbGpPWpGaD
Glimepiride—Leukopenia—Doxorubicin—lung cancer	0.000296	0.000485	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—lung cancer	0.000296	0.000484	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—lung cancer	0.000293	0.000478	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000292	0.00254	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000292	0.00254	CbGpPWpGaD
Glimepiride—Hypotension—Methotrexate—lung cancer	0.000292	0.000477	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—lung cancer	0.000291	0.000476	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—lung cancer	0.000287	0.000469	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—lung cancer	0.000286	0.000468	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—lung cancer	0.000286	0.000467	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—lung cancer	0.000282	0.000461	CcSEcCtD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000281	0.00245	CbGpPWpGaD
Glimepiride—Anxiety—Doxorubicin—lung cancer	0.000281	0.000459	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—lung cancer	0.00028	0.000458	CcSEcCtD
Glimepiride—ABCC8—Metabolism—HSD17B10—lung cancer	0.00028	0.00244	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTA4—lung cancer	0.000278	0.00242	CbGpPWpGaD
Glimepiride—Dyspnoea—Methotrexate—lung cancer	0.000278	0.000455	CcSEcCtD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000278	0.00242	CbGpPWpGaD
Glimepiride—Somnolence—Methotrexate—lung cancer	0.000277	0.000454	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—lung cancer	0.000276	0.000451	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—lung cancer	0.000275	0.00045	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—lung cancer	0.000275	0.000449	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTA4—lung cancer	0.000275	0.00239	CbGpPWpGaD
Glimepiride—Rash—Docetaxel—lung cancer	0.000273	0.000446	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—lung cancer	0.000273	0.000446	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—lung cancer	0.000272	0.000445	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—HSD17B10—lung cancer	0.000271	0.00236	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TF—lung cancer	0.000271	0.00236	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTA2—lung cancer	0.000271	0.00236	CbGpPWpGaD
Glimepiride—Decreased appetite—Methotrexate—lung cancer	0.000271	0.000444	CcSEcCtD
Glimepiride—Headache—Docetaxel—lung cancer	0.000271	0.000443	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—lung cancer	0.00027	0.000442	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—lung cancer	0.000269	0.00044	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—lung cancer	0.000269	0.00044	CcSEcCtD
Glimepiride—Shock—Doxorubicin—lung cancer	0.000266	0.000435	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—lung cancer	0.000265	0.000433	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—lung cancer	0.000264	0.000431	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GSTA1—lung cancer	0.000262	0.00228	CbGpPWpGaD
Glimepiride—Hyperhidrosis—Doxorubicin—lung cancer	0.000261	0.000427	CcSEcCtD
Glimepiride—ABCC8—Metabolism—CKB—lung cancer	0.00026	0.00227	CbGpPWpGaD
Glimepiride—Anorexia—Doxorubicin—lung cancer	0.000258	0.000421	CcSEcCtD
Glimepiride—Nausea—Docetaxel—lung cancer	0.000257	0.00042	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—lung cancer	0.000257	0.00042	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—lung cancer	0.000255	0.000417	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—lung cancer	0.000252	0.000413	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CKB—lung cancer	0.000252	0.0022	CbGpPWpGaD
Glimepiride—Urticaria—Methotrexate—lung cancer	0.000248	0.000405	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—AKR1C1—lung cancer	0.000247	0.00215	CbGpPWpGaD
Glimepiride—Abdominal pain—Methotrexate—lung cancer	0.000247	0.000403	CcSEcCtD
Glimepiride—ABCC8—Metabolism—GSTM2—lung cancer	0.000245	0.00213	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CNDP2—lung cancer	0.000245	0.00213	CbGpPWpGaD
Glimepiride—Insomnia—Doxorubicin—lung cancer	0.000244	0.0004	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—UGT1A1—lung cancer	0.000243	0.00212	CbGpPWpGaD
Glimepiride—Paraesthesia—Doxorubicin—lung cancer	0.000243	0.000397	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—lung cancer	0.000241	0.000394	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—lung cancer	0.00024	0.000393	CcSEcCtD
Glimepiride—CYP2C9—Metapathway biotransformation—UGT1A1—lung cancer	0.00024	0.00209	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000239	0.00208	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTMR3—lung cancer	0.000238	0.00207	CbGpPWpGaD
Glimepiride—Dyspepsia—Doxorubicin—lung cancer	0.000238	0.000389	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CNDP2—lung cancer	0.000237	0.00207	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM2—lung cancer	0.000237	0.00207	CbGpPWpGaD
Glimepiride—Decreased appetite—Doxorubicin—lung cancer	0.000235	0.000384	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000233	0.000381	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—lung cancer	0.000233	0.000381	CcSEcCtD
Glimepiride—ABCC8—Metabolism—PGAM1—lung cancer	0.000232	0.00202	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTMR3—lung cancer	0.000231	0.00201	CbGpPWpGaD
Glimepiride—Hypersensitivity—Methotrexate—lung cancer	0.00023	0.000376	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—BRAF—lung cancer	0.00023	0.002	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000228	0.00199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PGAM1—lung cancer	0.000225	0.00196	CbGpPWpGaD
Glimepiride—Asthenia—Methotrexate—lung cancer	0.000224	0.000366	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—BRAF—lung cancer	0.000223	0.00194	CbGpPWpGaD
Glimepiride—Feeling abnormal—Doxorubicin—lung cancer	0.000223	0.000364	CcSEcCtD
Glimepiride—ABCC8—Metabolism—CYP2A7—lung cancer	0.000221	0.00193	CbGpPWpGaD
Glimepiride—Gastrointestinal pain—Doxorubicin—lung cancer	0.000221	0.000361	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—lung cancer	0.000221	0.000361	CcSEcCtD
Glimepiride—ABCC8—Metabolism—SDC4—lung cancer	0.000217	0.00188	CbGpPWpGaD
Glimepiride—Urticaria—Doxorubicin—lung cancer	0.000215	0.000351	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CYP2A7—lung cancer	0.000215	0.00187	CbGpPWpGaD
Glimepiride—Abdominal pain—Doxorubicin—lung cancer	0.000214	0.000349	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—lung cancer	0.000213	0.000349	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—SDC4—lung cancer	0.00021	0.00183	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.00021	0.00183	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—HPGDS—lung cancer	0.000207	0.0018	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—HRAS—lung cancer	0.000207	0.0018	CbGpPWpGaD
Glimepiride—Dizziness—Methotrexate—lung cancer	0.000206	0.000337	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.000201	0.00175	CbGpPWpGaD
Glimepiride—Hypersensitivity—Doxorubicin—lung cancer	0.000199	0.000325	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.000198	0.00173	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000198	0.00173	CbGpPWpGaD
Glimepiride—Vomiting—Methotrexate—lung cancer	0.000198	0.000324	CcSEcCtD
Glimepiride—ABCC8—Metabolism—RRM1—lung cancer	0.000197	0.00172	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTA3—lung cancer	0.000197	0.00172	CbGpPWpGaD
Glimepiride—Rash—Methotrexate—lung cancer	0.000197	0.000322	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—lung cancer	0.000197	0.000321	CcSEcCtD
Glimepiride—Headache—Methotrexate—lung cancer	0.000195	0.00032	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—lung cancer	0.000194	0.000317	CcSEcCtD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000194	0.00169	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—MDM2—lung cancer	0.000192	0.00167	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—RAF1—lung cancer	0.000192	0.00167	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—RRM1—lung cancer	0.000191	0.00166	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTA3—lung cancer	0.000191	0.00166	CbGpPWpGaD
Glimepiride—Pruritus—Doxorubicin—lung cancer	0.000191	0.000313	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—AVP—lung cancer	0.000188	0.00164	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—MDM2—lung cancer	0.000187	0.00162	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—RAF1—lung cancer	0.000186	0.00162	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—B4GALT5—lung cancer	0.000185	0.00161	CbGpPWpGaD
Glimepiride—Nausea—Methotrexate—lung cancer	0.000185	0.000303	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—lung cancer	0.000185	0.000302	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000182	0.00159	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000181	0.00158	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTA4—lung cancer	0.00018	0.00157	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—B4GALT5—lung cancer	0.00018	0.00157	CbGpPWpGaD
Glimepiride—Dizziness—Doxorubicin—lung cancer	0.000179	0.000292	CcSEcCtD
Glimepiride—ABCC8—Metabolism—GSTA2—lung cancer	0.000176	0.00153	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTA4—lung cancer	0.000175	0.00152	CbGpPWpGaD
Glimepiride—Vomiting—Doxorubicin—lung cancer	0.000172	0.000281	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—GSTA2—lung cancer	0.00017	0.00148	CbGpPWpGaD
Glimepiride—Rash—Doxorubicin—lung cancer	0.00017	0.000279	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—lung cancer	0.00017	0.000278	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.00017	0.00148	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTA1—lung cancer	0.00017	0.00148	CbGpPWpGaD
Glimepiride—Headache—Doxorubicin—lung cancer	0.000169	0.000277	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP2E1—lung cancer	0.000169	0.00147	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCC3—lung cancer	0.000168	0.00146	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	0.000166	0.00145	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTA1—lung cancer	0.000164	0.00143	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCC3—lung cancer	0.000163	0.00142	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKR1C1—lung cancer	0.000162	0.00141	CbGpPWpGaD
Glimepiride—Nausea—Doxorubicin—lung cancer	0.00016	0.000262	CcSEcCtD
Glimepiride—ABCC8—Metabolism—UGT1A1—lung cancer	0.000158	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKR1C1—lung cancer	0.000158	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UGT1A1—lung cancer	0.000153	0.00133	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNG11—lung cancer	0.000152	0.00132	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNG11—lung cancer	0.000147	0.00128	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALDOA—lung cancer	0.000145	0.00126	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOA1—lung cancer	0.000144	0.00125	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000141	0.00123	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NCOA3—lung cancer	0.000141	0.00122	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALDOA—lung cancer	0.00014	0.00122	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—lung cancer	0.000139	0.00121	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	0.000137	0.00119	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADCY1—lung cancer	0.000137	0.00119	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG2—lung cancer	0.000137	0.00119	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NCOA3—lung cancer	0.000136	0.00119	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ENO2—lung cancer	0.000134	0.00117	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HPGDS—lung cancer	0.000134	0.00117	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPP2R1B—lung cancer	0.000133	0.00116	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADCY1—lung cancer	0.000133	0.00115	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG2—lung cancer	0.000133	0.00115	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—lung cancer	0.00013	0.00113	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HPGDS—lung cancer	0.00013	0.00113	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ENO2—lung cancer	0.00013	0.00113	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPP2R1B—lung cancer	0.000129	0.00112	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2A6—lung cancer	0.000129	0.00112	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCLC—lung cancer	0.000129	0.00112	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—lung cancer	0.000128	0.00111	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—lung cancer	0.000126	0.0011	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	0.000126	0.0011	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCLC—lung cancer	0.000125	0.00108	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2A6—lung cancer	0.000125	0.00108	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ENO1—lung cancer	0.000122	0.00106	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000122	0.00106	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—lung cancer	0.000121	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	0.00012	0.00104	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ENO1—lung cancer	0.000118	0.00103	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—lung cancer	0.000114	0.000992	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2E1—lung cancer	0.000109	0.000951	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NQO1—lung cancer	0.000108	0.000941	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COL4A3BP—lung cancer	0.000107	0.000928	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AZIN2—lung cancer	0.000107	0.000928	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2E1—lung cancer	0.000106	0.000922	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—HRAS—lung cancer	0.000106	0.000919	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NQO1—lung cancer	0.000105	0.000912	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RAF1—lung cancer	0.000103	0.000897	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—HRAS—lung cancer	0.000102	0.000891	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	9.94e-05	0.000865	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—STK11—lung cancer	9.74e-05	0.000848	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	9.63e-05	0.000838	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—STK11—lung cancer	9.45e-05	0.000822	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ATP5H—lung cancer	9.06e-05	0.000789	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—POMC—lung cancer	9.04e-05	0.000786	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—lung cancer	9.01e-05	0.000784	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAT—lung cancer	8.77e-05	0.000763	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—lung cancer	8.74e-05	0.000761	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—lung cancer	8.53e-05	0.000743	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAT—lung cancer	8.51e-05	0.00074	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TYMS—lung cancer	8.38e-05	0.000729	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	8.33e-05	0.000725	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—lung cancer	8.28e-05	0.000721	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—lung cancer	8.27e-05	0.00072	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TYMS—lung cancer	8.13e-05	0.000707	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLBD1—lung cancer	8.08e-05	0.000703	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—lung cancer	8.03e-05	0.000699	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.95e-05	0.000692	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—lung cancer	7.85e-05	0.000683	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ERCC2—lung cancer	7.79e-05	0.000678	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—lung cancer	7.62e-05	0.000663	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ERCC2—lung cancer	7.55e-05	0.000657	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B10—lung cancer	7.39e-05	0.000643	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CKB—lung cancer	6.87e-05	0.000598	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA1—lung cancer	6.74e-05	0.000586	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA1—lung cancer	6.53e-05	0.000569	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM2—lung cancer	6.46e-05	0.000562	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CNDP2—lung cancer	6.46e-05	0.000562	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTMR3—lung cancer	6.28e-05	0.000547	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—lung cancer	6.15e-05	0.000535	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PGAM1—lung cancer	6.12e-05	0.000533	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—lung cancer	5.96e-05	0.000519	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—POMC—lung cancer	5.86e-05	0.00051	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2A7—lung cancer	5.84e-05	0.000508	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SDC4—lung cancer	5.72e-05	0.000497	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CREBBP—lung cancer	5.7e-05	0.000496	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—POMC—lung cancer	5.68e-05	0.000494	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CREBBP—lung cancer	5.53e-05	0.000481	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CD—lung cancer	5.41e-05	0.000471	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—lung cancer	5.34e-05	0.000465	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CD—lung cancer	5.24e-05	0.000456	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—RRM1—lung cancer	5.21e-05	0.000453	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA3—lung cancer	5.21e-05	0.000453	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—lung cancer	5.18e-05	0.00045	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—B4GALT5—lung cancer	4.89e-05	0.000426	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA4—lung cancer	4.76e-05	0.000414	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CB—lung cancer	4.71e-05	0.00041	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—lung cancer	4.67e-05	0.000406	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.65e-05	0.000405	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA2—lung cancer	4.64e-05	0.000404	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CB—lung cancer	4.57e-05	0.000398	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—lung cancer	4.53e-05	0.000394	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTA1—lung cancer	4.48e-05	0.00039	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCC3—lung cancer	4.43e-05	0.000385	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKR1C1—lung cancer	4.29e-05	0.000373	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UGT1A1—lung cancer	4.16e-05	0.000362	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—lung cancer	4.07e-05	0.000354	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNG11—lung cancer	4.01e-05	0.000349	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.99e-05	0.000347	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—lung cancer	3.95e-05	0.000344	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—EP300—lung cancer	3.88e-05	0.000338	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDOA—lung cancer	3.82e-05	0.000333	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—EP300—lung cancer	3.77e-05	0.000328	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NCOA3—lung cancer	3.71e-05	0.000323	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.65e-05	0.000317	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADCY1—lung cancer	3.61e-05	0.000314	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG2—lung cancer	3.61e-05	0.000314	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPGDS—lung cancer	3.54e-05	0.000308	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENO2—lung cancer	3.54e-05	0.000308	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPP2R1B—lung cancer	3.52e-05	0.000306	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.47e-05	0.000302	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—lung cancer	3.43e-05	0.000299	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCLC—lung cancer	3.39e-05	0.000295	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2A6—lung cancer	3.39e-05	0.000295	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.38e-05	0.000294	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENO1—lung cancer	3.22e-05	0.00028	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.2e-05	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.16e-05	0.000275	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2E1—lung cancer	2.88e-05	0.000251	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—lung cancer	2.87e-05	0.00025	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NQO1—lung cancer	2.85e-05	0.000248	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.79e-05	0.000243	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—lung cancer	2.79e-05	0.000242	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.77e-05	0.000241	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—STK11—lung cancer	2.57e-05	0.000224	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.41e-05	0.00021	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—lung cancer	2.38e-05	0.000207	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—lung cancer	2.35e-05	0.000204	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAT—lung cancer	2.32e-05	0.000201	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.3e-05	0.0002	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—lung cancer	2.28e-05	0.000198	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—lung cancer	2.25e-05	0.000196	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TYMS—lung cancer	2.21e-05	0.000192	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—lung cancer	2.19e-05	0.00019	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—lung cancer	2.07e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ERCC2—lung cancer	2.06e-05	0.000179	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA1—lung cancer	1.78e-05	0.000155	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.7e-05	0.000148	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—lung cancer	1.62e-05	0.000141	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—POMC—lung cancer	1.55e-05	0.000134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CREBBP—lung cancer	1.51e-05	0.000131	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CD—lung cancer	1.43e-05	0.000124	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—lung cancer	1.41e-05	0.000123	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CB—lung cancer	1.24e-05	0.000108	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—lung cancer	1.23e-05	0.000107	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—lung cancer	1.07e-05	9.35e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—EP300—lung cancer	1.03e-05	8.92e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—lung cancer	7.58e-06	6.6e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—lung cancer	6.19e-06	5.39e-05	CbGpPWpGaD
